“Exploring the Potential of Drug Repurposing: Detection of Cystic Fibrosis Transmembrane Conductance Regulator As a Biomarker in Breast Cancer Patients”. 2023. Precision Medicine Communications 3 (1): 11-26. https://doi.org/10.55627/pmc.003.01.0300.